News for Cara Therapeutics, Inc. (CARA)

PR NewswireNEW YORK, Jan. 7, 2025 NEW YORK, Jan. 7, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following comp

Cara Therapeutics (CARA) stock jumps 32% following a 1-for-12 reverse stock split to regain Nasdaq compliance. Read more here.

**media[501337]**

Biopharmaceutical company Cara Therapeutics (CARA) announced on Friday a 1-for-12 reverse stock split to regain compliance with Nasdaq's minimum bid price rule.

Cara Therapeutics enacts reverse stock split

STAMFORD, Conn., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. ( CARA) (the ”œCompany”), today announced that a 1-for-12 reverse stock split of

PR NewswireNEW YORK, Dec. 23, 2024 NEW YORK, Dec. 23, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following co

NEW YORK, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed

Cara Therapeutics (CARA) stock slipped in premarket after the company announced a merger deal with Tvardi Therapeutics. Read more here.

Cara Therapeutics, Inc. (CARA), Wednesday announced that the company has entered into a merger agreement with Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company.

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. This article was generated by Benzinga's automated content engine and r...

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. This article was generated by Benzinga's automated content engine and r...

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. This article was generated by Benzinga's automated content engine and r...

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. This article was generated by Benzinga's automated content engine and r...

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. This article was generated by Benzinga's automated content engine and r...

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. This article was generated by Benzinga's automated content engine and r...

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. This article was generated by Benzinga's automated content engine and r...

Cara Therapeutics Announces Exploration of Strategic Alternatives Cara Therapeutics, Inc. (Nasdaq: CARA)…

Loading... Loading... U.S. stocks traded mixed toward the end of trading, with the S&P 500 edging higher on Thursday. The Dow traded down 0.21% to 38,629.82 w...